The Valley Desk

Clinical trial reportJournal of the American Academy of Child and Adolescent PsychiatryPublished

Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of the American Academy of Child and Adolescent Psychiatry
Published
Subject terms
Humans; Ketamine; Midazolam; Antidepressive Agents; Double-Blind Method; Adolescent; Child; Female; Male; Suicidal Ideation; Suicide Prevention; Major Depressive Disorder
PubMed ID
40058488
Added to directory
Source checked

Report a correction or request removal